CLINICAL TRIALS PROFILE FOR OPSUMIT
✉ Email this page to a colleague
All Clinical Trials for OPSUMIT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02050802 ↗ | Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects | Completed | Actelion | Phase 1 | 2011-08-01 | The study is intended to demonstrate that macitentan does not have an effect on cardiac repolarization exceeding the threshold of regulatory concern after repeated administration of daily oral doses of 10 and 30 mg to healthy male and female subjects. |
| NCT02126943 ↗ | OPsumit USers Registry | Completed | Actelion | 2014-04-30 | Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting. | |
| NCT02476864 ↗ | Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults | Completed | Actelion | Phase 1 | 2015-08-01 | A study conducted in healthy adults to investigate if a new macitentan tablet leads to the same fate of macitentan in the body (time of onset, time of presence, amount in the blood) as the marketed macitentan tablet. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OPSUMIT
Condition Name
Clinical Trial Locations for OPSUMIT
Trials by Country
Clinical Trial Progress for OPSUMIT
Clinical Trial Phase
Clinical Trial Sponsors for OPSUMIT
Sponsor Name
